Andrew Firlik is the Co-Founder and Managing Partner of JAZZ Venture Partners. See sector focus and contact routes.
Andrew Firlik is the Co-Founder and Managing Partner of JAZZ Venture Partners, a firm he launched in 2015 with a background as a board-certified neurosurgeon and former entrepreneur who founded Northstar Neuroscience. His investment thesis targets early to growth-stage companies (seed through Series B) that leverage deep technology to enhance human potential, focusing on sectors like neuroscience, digital health, artificial intelligence, biotech, and human performance. Firlik typically invests between $100,000 and $5.0 million with a sweet spot of $1.5 million, often participating in rounds ranging from seed to Series B. Notable portfolio companies include Zus Health, Yumi, Magnus Medical, and Thrive Global, which span digital health, nutrition technology, and mental wellness. He distinguishes himself through a unique clinical perspective, having published over 50 medical articles and served as a clinical professor at Yale and NYU before transitioning to venture capital. This medical expertise informs his distinctive point of view on optimizing human health and performance through technology, a theme central to the firm’s mission.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Norwalk.
Investors like Andrew Firlik · Full investor directory · Investor access · Company funding database